Printer Friendly

IVF AMERICA INC. FILES REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING OF COMMON STOCK

 IVF AMERICA INC. FILES REGISTRATION STATEMENT
 FOR INITIAL PUBLIC OFFERING OF COMMON STOCK
 GREENWICH, Conn., May 6 /PRNewswire/ -- IVF America Inc. today announced that it has filed a registration statement with the Securities and Exchange Commission covering a proposed initial public offering of 1,875,000 shares of common stock. The issue is expected to be priced between $8 and $10 and become effective in June. H.J. Meyers & Co. Inc. is the managing underwriter of the offering.
 IVF America Inc. is engaged in managing clinical facilities which utilize the company's assisted reproductive technology ("ART") program for infertile couples. Based on industry statistics, IVF America believes more ART therapeutic procedures are performed in the United States annually at the clinical facilities managed by the company than at the facilities of any other medical institution or affiliated group. The company's current ART procedures include in vitro fertilization ("IVF"), gamete intrafallopian transfer ("GIFT"), microinsemination, zygote intrafallopian transfer ("ZIFT"), tubal embryo transfer ("TET") and donor egg programs. IVF America utilizes technology developed at Monash University, Melbourne, Australia, a pioneer in ART therapies.
 A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement has become effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state. This offer is made only by Prospectus, a copy of which may be obtained from H.J. Meyers & Co. Inc. 356 N. Camden Drive, Beverly Hills, CA 90210.
 -0- 5/6/92
 /CONTACT: Richard A. Rappaport of H.J. Meyers & Co., 310-278-7880, for IVF America/ CO: IVF America Inc. ST: Connecticut IN: MTC SU: OFR


KJ-EH -- LA005 -- 6919 05/06/92 09:04 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 6, 1992
Words:339
Previous Article:PERFORMANCE NUTRITION SIGNS LONG JUMP RECORD HOLDER MIKE POWELL TO ENDORSEMENT CONTRACT
Next Article:ARLINGTON SOFTWARE DESIGN FIRM LAUNCHES NATIONAL MARKETING CAMPAIGN FOR PROGRAM THAT PREVENTS SCHEDULING CONFLICTS OVER USE OF CONFERENCE ROOMS AND...


Related Articles
UCC INVESTORS ANNOUNCES IT INTENDS TO FILE NEXT WEEK AN INITIAL PUBLIC OFFERING OF STOCK AND DEBT OF $700 MILLION
ALPHA-BETA TECHNOLOGY FILES REGISTRATION STATEMENT WITH SEC FOR INITIAL PUBLIC OFFERING OF TWO MILLION SHARES OF COMMON STOCK
NATURAL WONDERS, INC. ANNOUNCES FILING OF REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING
CLINICOM FILES REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING OF 875,000 COMMON SHARES
COATING SCIENCES FILES INITIAL PUBLIC OFFERING OF COMMON STOCK
PERCEPTRON, INC. FILES REGISTRATION STATEMENT
IVF AMERICA INC. FILES REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING OF COMMON STOCK
SCHERER ANNOUNCES AN INITIAL PUBLIC OFFERING OF ITS SUBSIDIARY, PACO PHARMACEUTICAL SERVICES, INC.
IVF AMERICA ANNOUNCES PROPOSED UNDERWRITTEN CONVERTIBLE PREFERRED STOCK OFFERING
IVF AMERICA FILES STATEMENT FOR CONVERTIBLE PREFERRED STOCK OFFERING

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters